IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited, Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2022. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30, 46, Part A, Para A of Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with corresponding circulars and notifications issued there under, it is hereby informed that the management of the Company will be meeting with prospective investors/ mutual funds etc at various places in Mumbai between 12 & 13 April 2022. The meeting shall be sort of non-deal roadshow, where no unpublished price sensitive information (UPSI) will be shared during the aforesaid meetings. In this regard, the discussion presentation that may be presented during such meetings by Management is attached herewith. The same is also available on Company''s website i.e. www.iolcp.com Note: The schedule of the roadshow is subject to change. Changes may happen due to exigencies on the part of Investor/ Company. This is for your information and records. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification On Price Movement
With reference to your mail, reference no.:L/SURV/ONL/PV/SR/2022-2023/2222 dated 08.04.2022, we wish to submit that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. We would like to further inform and clarify that all the information furnished by the Company is in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. We trust this will clarify your queries. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification sought from IOL Chemicals & Pharmaceuticals Ltd
The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on April 8, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Submission Of Voting Result Of Postal Ballot (Through Remote E-Voting) And Scrutinizer''s Report Dated 19Th March 2022
Submission of Voting Result of Postal Ballot (through Remote E-voting) and Scrutinizer''s Report dated 19th March 2022 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation Of Incorporation Of Wholly Owned Subsidiary Under Section 8 Of The Companies Act, 2013
Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that IOL-Foundation has been incorporated as wholly owned subsidiary of the Company under Section 8 of the Companies Act, 2013 on 15th March 2022. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/ CFD/CMD/4/ 2015 dated 9th September, 2015 are attached as an Annexure A to this letter. This is for information and record. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In continuation to our letter dated 3rd February 2022 regarding intimation of Schedule of analyst/ investors conference call - Q3 FY22, please find attached herewith the transcript of Earnings Conference Call organized by the Company on 8th February 2022 post declaration of audited financial results for the quarter and nine month ended 31st December 2021. This is for information and record.